SC refused to restrained Patanjali Ayurved from using the trademark CORONIL
SC refused to restrained Patanjali Ayurved from using the trademark CORONIL
On August 27,Supreme Court has given a major relief to Patanjali Ayurved Limited, quashed the petition against him on the trademark claim of “CORONIL”.
CORONIL has been launched by Patanjali Ayurved Limited. On July 1, the Union AYUSH ministry explicitly stated that company can sell “CORONIL”as a drug not as a cure for coronavirus .
A panel of Judges headed by Chief Justice of India , SA Bobde ,comprising other judges Justice AS Bopanna and Justice V Ramasubramanian denied to intrude into an interim order passed by a division bench of Madras HC. SC refused to restrained Patanjali Ayurved from using the trademark “CORONIL” and can sold their product as an immunity booster in this pandemic .
The court said that at present, when people are immensely affected by the corona, they are engaged in taking drugs and medicines that increase immunity, asking to change the name at such a time will increase people’s problems.
On August 6, a High Court judge bench restrained Patanjali from using the trademark ‘CORONIL’and also imposed a fine of Rs. 10 lakh on it in a trademark infringement suit filed by a private firm Aruda Engineers Private Limited .
The Petitioner claimed that CORONIL has registered as a mark for heavy machinery and containment units since 1993, CORONIL -213 SPL and CORONIL-92B and has been sustained since then. They further stated that the right over trademark valid till 2027. Though product sold by Patanjali are different it would amount to violation of our right and also affect the goodwill of the company.
Now this matter will only hear in Madras High Court in September.
By Priya Kumari
